# Atrial Cardiomyopathy in Patients With Cardiovascular-Kidney-Metabolic Syndrome: Non-invasive Characterization

> **NCT07697469** · — · NOT_YET_RECRUITING · sponsor: **Grigore T. Popa University of Medicine and Pharmacy** · enrollment: 200 (estimated)

## Conditions studied

- Cardiovascular-Kidney-Metabolic Syndrome
- Atrial Cardiomyopathy
- Atrial Fibrillation
- Chronic Kidney Disease
- Metabolic Syndrome

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07697469
- **Lead sponsor:** Grigore T. Popa University of Medicine and Pharmacy
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-10
- **Primary completion:** 2027-10
- **Final completion:** 2028-04
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-07-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07697469

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07697469, "Atrial Cardiomyopathy in Patients With Cardiovascular-Kidney-Metabolic Syndrome: Non-invasive Characterization". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07697469. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*